Sponsor intelligence · OTHER
Clinical trials sponsored by
IRCCS Azienda Ospedaliero-Universitaria Di Bologna.
Real, source-linked trial activity for IRCCS Azienda Ospedaliero-Universitaria Di Bologna: 2 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Oct 7, 2026. Source-linked, daily-refreshed.
N/A 1PHASE3 1
Newest IRCCS Azienda Ospedaliero-Universitaria Di Bologna trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 1d ago | INSL3 as a Biomarker of Pubertal Activation: Role in Evaluating Precoc | N/A | RECRUITING | ↗ |
| 56d ago | Targeted Versus Standard Peri-operative Antibiotic Prophylaxis in Pati | Ph 3 | NOT_YET_RECRUITING | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for IRCCS Azienda Ospedaliero-Universitaria Di Bologna (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.